Sarcoma News

Rates of Kaposi’s sarcoma and lymphoma were highest within the first year of antiretroviral treatment, but after the first year, other non–AIDS-defining cancers comprised most of the cancer burden for those with HIV, researchers reported in Clinical Infectious Diseases.

The FDA recently expanded the approved indications for the monoclonal antibody denosumab to include treatment of adults and some adolescents with giant cell tumor of the bone.

Treatment with the rapamycin inhibitor ridaforolimus decreased the risk for mortality by 28% and delayed tumor progression in patients with metastatic sarcoma who previously benefitted from chemotherapy, according to results of a phase 3 study.

Researchers from the Rizzoli Orthopaedic Institute found that tumor grade was the greatest predictor of survival in patients with pelvic chondrosarcomas.

Thoracic aortic endografting allowed safe en bloc resection of tumors invading the aortic wall, particularly for tumors that extended into the aortic wall and the spine, according to results of a retrospective study presented at the American Association for Thoracic Surgery Annual Meeting.

Thoracic aortic endografting allowed safe en bloc resection of tumors invading the aortic wall, particularly for tumors that extended into the aortic wall and the spine, according to results of a retrospective study presented at the American Association for Thoracic Surgery Annual Meeting.

Two straightforward, multi-institution nomograms accurately predicted OS and DFS in a cohort of patients with retroperitoneal soft tissue sarcoma.

Two straightforward, multi-institution nomograms accurately predicted OS and DFS in a cohort of patients with retroperitoneal soft tissue sarcoma.

CHICAGO — After primary resection, patients with lower extremity and upper extremity bone or soft tissue sarcomas treated with either limb salvage or amputation had physical and mental health scores similar to normative values, but patients who underwent an amputation self-reported better mental health scores.

New results from the prospective, longitudinal Life Span Study of Japanese atomic bomb survivors from Hiroshima and Nagasaki show that low levels of exposure to ionizing radiation may result in soft-tissue sarcoma, and 1 Gy doses nearly doubled the survivors’ sarcoma risk.